Biochemistry of neuroendocrine tumours

被引：102

作者：

de Herder, Wouter W. ^{[1
]}

机构：

[1] Erasmus MC, Dept Internal Med, Sector Endocrinol, NL-3015 GCE Rotterdam, Netherlands

来源：

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2007年 / 21卷 / 01期

关键词：

serotonin; 5-HIAA; carcinoid; insulinoma; gastrinoma; VIPoma; glucagonoma; somatostatinoma; chromogranins; neuron-specific enolase (NSE); alpha-subunits of the glycoprotein hormones; catecholamines; pancreatic polypeptide (PP); ghrelin; adrenomedullin;

D O I：

10.1016/j.beem.2006.12.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Several circulating or urinary tumour markers can be used for the diagnosis and follow-up of functioning and clinically non-functioning neuroendocrine tumours of the pancreatic islet cells and intestinal tract. Among the specific tumour markers are serotonin and its metabolites e.g. 5-hydroxyindoleacetic acid (5-HIAA) - in carcinoid tumours and the carcinoid syndrome, insulin and its precursors or breakdown products in insulinoma, and gastrin in gastrinoma. Plasma vasointestinal polypeptide (VIP) determinations have been used in the diagnosis of VIPoma, plasma glucagon for glucagonoma, and serum somatostatin for somatostatinoma. Among the tumour-non-specific markers are: chromogranins, neuron-specific enolase (NSE), alpha-subunits of the glycoprotein hormones, catecholamines, pancreatic polypeptide (PP), ghrelin and adrenomedullin.

引用

页码：33 / 41

页数：9

共 50 条

[1]

Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO

[2]

2-8

[3] Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours [J].

Baudin, E ;

Gigliotti, A ;

Ducreux, R ;

Ropers, J ;

Comoy, E ;

Sabourin, JC ;

Bidart, JM ;

Cailleux, AF ;

Bonacci, R ;

Ruffié, P ;

Schlumberger, M .

BRITISH JOURNAL OF CANCER, 1998, 78 (08) :1102-1107

[4] Carcinoid tumour [J].

Caplin, ME ;

Buscombe, JR ;

Hilson, AJ ;

Jones, AL ;

Watkinson, AF ;

Burroughs, AK .

LANCET, 1998, 352 (9130) :799-805

[5] Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: Identification of one pancreatic ghrelinoma [J].

Corbetta, S ;

Peracchi, M ;

Cappiello, V ;

Lania, A ;

Lauri, E ;

Vago, L ;

Beck-Peccoz, P ;

Spada, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3117-3120

[6]

de Herder W W, 2004, Neuroendocrinology, V80 Suppl 1, P20, DOI 10.1159/000080735

[7] Considerations concerning a tailored, individualized therapeutic management of patients with (neuro)endocrine tumours of the gastrointestinal tract and pancreas [J].

de Herder, WW ;

Krenning, EP ;

van Eijck, CHJ ;

Lamberts, SWJ .

[8] CHROMOGRANIN-A - ITS ROLE IN ENDOCRINE FUNCTION AND AS AN ENDOCRINE AND NEUROENDOCRINE TUMOR-MARKER [J].

DEFTOS, LJ .

ENDOCRINE REVIEWS, 1991, 12 (02) :181-187

[9]

DEHERDER WW, 2005, CLIN GASTROENTEROLOG, V19, P705

[10]

DOCKRAY GJ, 2004, CLIN ENDOCRINOLOGY M, V18, P555

← 1 2 3 4 5 →